Literature DB >> 8875232

In vivo gene transfer to the human biliary tract.

S M Vickers1, J O Phillips, J D Kerby, J S Bynon, J A Thompson, D T Curiel.   

Abstract

The human biliary tract offers an excellent model for gene transfer studies for a variety of diseases localized to the liver. The aim of this study was to determine if a viable liver might be employed to study viral transfection of the human biliary system in order to mimic in vivo human experiments. Using a normal human liver initially procured for transplantation, but subsequently found unsuitable, and with an intact biliary tree, the hepatic vascular supply was accessed for continuous perfusion. The common and left hepatic biliary system was isolated by balloon catheterization. A replication defective adenoviral vector containing the Escherichia coli beta-galactosidase (lac Z) reporter gene (AdCMVLacZ) was injected into the catheter-isolated left and common bile duct lumen. Viral exposure to the right duct system was prevented by ligation. The bile duct segments were excised and prepared for enzymatic (X-gal) staining. Intense staining was observed in the biliary epithelium exposed to the adenoviral vector. No evidence of beta-galactosidase staining was noted in the unexposed biliary mucosa. We report direct transfection of biliary epithelial cells from normal human liver with a recombinant adenovirus. Our data suggest potential therapeutic applications for gene therapy of hepatobiliary disorders.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8875232

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  2 in total

1.  Development of a therapeutic adenoviral vector for cholangiocarcinoma combining tumor-restricted gene expression and infectivity enhancement.

Authors:  Peter Nagi; Selwyn M Vickers; Julia Davydova; Yasuo Adachi; Koichi Takayama; Shannon Barker; Victor Krasnykh; David T Curiel; Masato Yamamoto
Journal:  J Gastrointest Surg       Date:  2003 Mar-Apr       Impact factor: 3.452

2.  Combined cytosine deaminase expression, 5-fluorocytosine exposure, and radiotherapy increases cytotoxicity to cholangiocarcinoma cells.

Authors:  L C Pederson; S M Vickers; D J Buchsbaum; S R Kancharla; M S Mayo; D T Curiel; M A Stackhouse
Journal:  J Gastrointest Surg       Date:  1998 May-Jun       Impact factor: 3.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.